Contract facts
UnrestrictedNo full NAICS 541714 intel page yet. Browse NAICS intelligence
Eo 14398 - the Purpose of This Modification Is To: the Vendor Requests an Extension of 12 Months for This Project is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by National Institute for Pharmaceutical Technology and Education, Inc. Estimated value $3M ($3M obligated). Current period of performance ends Sep 28, 2027. Last award drew 165 bidders. Place of performance: SILVER SPRING MD. Related solicitation FDABAA2200123.
Eo 14398 - the purpose of this modification is to: the vendor requests an extension of 12 months for this project. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Sep 28, 2027 (346 days remaining). Agencies typically plan 12–18 months ahead — at 11.4 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75F40122C00192? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNational Institute for Pharmaceutical Technology and Education, Inc — $1.5M obligated across 3 awards (firm-wide, all agencies).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40122C00192?
75F40122C00192 (Eo 14398 - the purpose of) is a Fda Office Of Acq Grant Svcs award with a potential value of $3M, currently held by National Institute for Pharmaceutical Technology and Education, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40122C00192?
Fda Office Of Acq Grant Svcs awarded 75F40122C00192 to National Institute for Pharmaceutical Technology and Education, Inc (potential $3M).
Who is the incumbent on 75F40122C00192?
National Institute for Pharmaceutical Technology and Education, Inc is the incumbent with $1.5M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Sep 28, 2027.
When does National Institute for Pharmaceutical Technology and Education, Inc’s 75F40122C00192 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75F40122C00192? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.